ライフサイエンスコーパス: contrast echocardiography

1 d ethanol injection technique and the use of contrast echocardiography.

2 as determined by intravenous (IV) myocardial contrast echocardiography.

3 ho enhancement by QW7437 microbubbles during contrast echocardiography.

4 w reserve are possible using second harmonic contrast echocardiography.

5 rial pacing with high-resolution Doppler and contrast echocardiography.

6 PAVA was assessed using transthoracic saline contrast echocardiography.

7 the presence and size of a PFO using saline contrast echocardiography.

8 lative to the cell counts at sham myocardial contrast echocardiography.

9 ocardial perfusion produced by IV myocardial contrast echocardiography.

10 while maintaining PM perfusion, confirmed by contrast echocardiography.

11 Myocardial contrast echocardiography accurately differentiates 'stu

12 size and perfusion defect size on myocardial contrast echocardiography after reperfusion (r = .82), w

13 o a stenosis can be measured with myocardial contrast echocardiography, allowing coronary stenosis de

14 Myocardial contrast echocardiography allows real-time echocardiogra

15 arct size and perfusion defect on myocardial contrast echocardiography also remained good in the pres

16 m and detect coronary stenosis by myocardial contrast echocardiography and (2) compared the response

17 graphy and fluoroscopy as well as epicardial contrast echocardiography and angiography at the time of

18 ients with the use of dipyridamole real-time contrast echocardiography and followed them for a median

19 We sought to compare bubble contrast echocardiography and pulmonary angiography in d

20 e heart block, but the risk was reduced with contrast echocardiography and slow ethanol injection.

21 specimens obtained 24 hours after myocardial contrast echocardiography and then either fresh frozen o

22 inase (CK), smaller septal area opacified by contrast echocardiography, and higher residual gradient

23 ological advances have positioned myocardial contrast echocardiography as a safe and feasible techniq

24 ological advances have positioned myocardial contrast echocardiography as a safe, practical bedside t

25 y underwent high-mechanical-index myocardial contrast echocardiography at 15 Hz to allow measurement

26 hage (n = 12) for 1 week prior to myocardial contrast echocardiography at 85% of gestation.

27 iovenous shunting was evaluated using saline contrast echocardiography at each stage.

28 On myocardial contrast echocardiography, both MB(YSPSL) and MB(Ab) pro

29 Myocardial contrast echocardiography can assess myocardial perfusio

30 Myocardial contrast echocardiography can be used to assess perfusio

31 Contrast echocardiography can rapidly and accurately pro

32 nonrejecting myocardium and that myocardial contrast echocardiography can therefore detect acute rej

33 Contrast echocardiography (CE) has improved visualizatio

34 ardiography (HE), and after intravenous (IV) contrast echocardiography (CE) using a score for each of

35 Myocardial contrast echocardiography compares favorably with LDDE i

36 Real-time contrast echocardiography defect size and quantitative r

37 Real-time contrast echocardiography defect size varies throughout

38 MBF can be quantified with myocardial contrast echocardiography during a venous infusion of mi

39 Contrast echocardiography for detection of intrapulmonar

40 phy for assessment of inotropic reserve, and contrast echocardiography for evaluation of microvascula

41 teams; 3) use of (3-dimensional) myocardial contrast echocardiography for selecting the correct sept

42 Myocardial contrast echocardiography has been shown to have good co

43 erfusion analysis using real-time myocardial contrast echocardiography has been shown to have higher

44 Myocardial contrast echocardiography has been studied in multiple c

45 sis of myocardial perfusion using myocardial contrast echocardiography has higher diagnostic accuracy

46 dex imaging techniques (real-time myocardial contrast echocardiography) have the advantage of permitt

47 , magnetic resonance imaging, and myocardial contrast echocardiography, have emerged as techniques wi

48 Contrast echocardiography identified three patients with

49 Myocardial contrast echocardiography images and radiolabeled micros

50 n (MP) imaging during dipyridamole real-time contrast echocardiography improves the sensitivity to de

51 t with continuous high-mechanical-index (MI) contrast echocardiography in 15 open-chest dogs.

52 Myocardial contrast echocardiography in a short-axis (open-chest) o

53 a review of the current status of myocardial contrast echocardiography in acute coronary syndromes.

54 xciting exploration of the expanding role of contrast echocardiography in clinical practice.

55 The role of contrast echocardiography in enhancing technically diffi

56 hnique for assessing myocardial perfusion by contrast echocardiography in humans.

57 creased during hypoglycemia using myocardial contrast echocardiography in patients with type 1 diabet

58 ontrast agent microbubbles during myocardial contrast echocardiography in rats, and the numbers of in

59 The study examined the value of contrast echocardiography in the assessment of left vent

60 with impaired tissue perfusion on myocardial contrast echocardiography in the setting of myocardial i

61 Recent technical innovations in contrast echocardiography, including pulse inversion ima

62 Advances in novel applications of contrast echocardiography, including targeted delivery o

63 Contrast echocardiography indicated both pulmonary and m

64 Myocardial contrast echocardiography induces bioeffects in rat hear

65 Integrating contrast echocardiography into the ED evaluation of CP m

66 Myocardial contrast echocardiography is a new technique that utiliz

67 Myocardial contrast echocardiography is a recently developed techni

68 We have reported that contrast echocardiography is a sensitive screening test

69 Bubble contrast echocardiography is more sensitive in detecting

70 surgical septal reduction therapy, guided by contrast echocardiography, is an effective procedure for

71 Postdestruction time-intensity myocardial contrast echocardiography kinetic data were fit to the e

72 However, contrast echocardiography lacks specificity because many

73 Myocardial contrast echocardiography may be more versatile than per

74 esigned to determine the value of myocardial contrast echocardiography (MCE) and dobutamine echocardi

75 etermine the relative accuracy of myocardial contrast echocardiography (MCE) and low-dose dobutamine

76 sought to compare the accuracy of myocardial contrast echocardiography (MCE) and wall motion analysis

77 Because myocardial contrast echocardiography (MCE) assesses microvascular p

78 for detecting microbubbles during myocardial contrast echocardiography (MCE) based on the registratio

79 is study was to determine whether myocardial contrast echocardiography (MCE) can be used to detect co

80 f the study was to assess whether myocardial contrast echocardiography (MCE) can identify underlying

81 is study investigated whether (1) myocardial contrast echocardiography (MCE) can quantify changes in

82 ne whether three-dimensional (3D) myocardial contrast echocardiography (MCE) could provide an accurat

83 is study was to determine whether myocardial contrast echocardiography (MCE) during exogenous vasodil

84 Myocardial contrast echocardiography (MCE) has been used to evaluat

85 Myocardial contrast echocardiography (MCE) has been used to measure

86 Myocardial contrast echocardiography (MCE) has evolved into an impo

87 Myocardial contrast echocardiography (MCE) has undergone many advan

88 ermittent triggered and real-time myocardial contrast echocardiography (MCE) have been proposed to de

89 ta on the accuracy of intravenous myocardial contrast echocardiography (MCE) in detecting myocardial

90 accuracy of real-time imaging of myocardial contrast echocardiography (MCE) in detecting myocardial

91 Although defects on intracoronary myocardial contrast echocardiography (MCE) indicate loss of viabili

92 Myocardial contrast echocardiography (MCE) is an emerging technique

93 validate the ability of real-time myocardial contrast echocardiography (MCE) measures of opacificatio

94 ons, Albunex microbubbles used in myocardial contrast echocardiography (MCE) pass unimpeded through t

95 We sought to determine whether myocardial contrast echocardiography (MCE) performed before and ear

96 bundle-branch block (LBBB) using myocardial contrast echocardiography (MCE) to ascertain the value o

97 examined the ability of real-time myocardial contrast echocardiography (MCE) to delineate abnormaliti

98 We used myocardial contrast echocardiography (MCE) to evaluate the therapeu

99 rtaken to evaluate the ability of myocardial contrast echocardiography (MCE) to guide the targeted de

100 was to evaluate the potential for myocardial contrast echocardiography (MCE) to provoke microscale bi

101 s the feasibility and accuracy of myocardial contrast echocardiography (MCE) using standard imaging a

102 Myocardial contrast echocardiography (MCE) was performed before occ

103 Myocardial contrast echocardiography (MCE) was performed with high

104 tered as a constant infusion, and myocardial contrast echocardiography (MCE) was performed with the u

105 utamine echocardiography (DE) and myocardial contrast echocardiography (MCE) was superior to either t

106 We hypothesized that myocardial contrast echocardiography (MCE) with leukocyte-targeted

107 de microbubble (SonoVue)-enhanced myocardial contrast echocardiography (MCE) with single-photon emiss

108 tery, whether normal perfusion by myocardial contrast echocardiography (MCE) would accurately predict

109 luate the comparative accuracy of myocardial contrast echocardiography (MCE), quantitative rest-redis

110 eled microsphere-derived MBF, and myocardial contrast echocardiography (MCE)-derived myocardial perfu

111 ied noninvasively in humans using myocardial contrast echocardiography (MCE).

112 pharmacological stress agent for myocardial contrast echocardiography (MCE).

113 onic myocardial ischemia by using myocardial contrast echocardiography (MCE).

114 23 patients undergoing concurrent myocardial contrast echocardiography (MCE).

115 Myocardial contrast echocardiography molecular imaging was performe

116 ernating myocardium include 99mTc-sestamibi, contrast echocardiography, nuclear magnetic resonance sp

117 Myocardial contrast echocardiography performed early after PCS prov

118 ubble kinetics using quantitative myocardial contrast echocardiography permits the evaluation of myoc

119 Albumin microbubbles that are used for contrast echocardiography persist within the myocardial

120 Myocardial contrast echocardiography provides better sensitivity th

121 hocardiography during dipyridamole real-time contrast echocardiography provides independent, incremen

122 on/reperfusion using quantitative myocardial contrast echocardiography (QMCE).

123 Tissue Doppler and contrast echocardiography recently have emerged as impor

124 Myocardial contrast echocardiography risk area size (expressed as a

125 erfusion imaging (MPI) obtained by real-time contrast echocardiography (RTCE) and intravenous ultraso

126 ardial perfusion (MP) imaging with real-time contrast echocardiography (RTCE) improves the sensitivit

127 nt outcome after stress real-time myocardial contrast echocardiography (RTMCE) versus conventional st

128 Quantitative myocardial contrast echocardiography seems to overcome the expertis

129 QIPAVA , assessed by transthoracic saline contrast echocardiography, significantly increased as Pa

130 and portable hand-held echocardiography, to contrast echocardiography, stress echocardiography, and

131 Myocardial contrast echocardiography, thallium scintigraphy and any

132 measuring the increase in aBV on myocardial contrast echocardiography that occurs distally to the st

133 By contrast echocardiography, the bulging septum was locali

134 to evaluate the potential of second harmonic contrast echocardiography to assess coronary vasculature

135 ulsed and Doppler color flow ultrasound, and contrast echocardiography to evaluate flow in the ductus

136 We used myocardial contrast echocardiography to test the hypothesis that co

137 aim of this study was to evaluate myocardial contrast echocardiography using aortic root injections w

138 Myocardial contrast echocardiography using harmonic imaging and int

139 basis of detection of stenosis by myocardial contrast echocardiography using venous administration of

140 In contrast, echocardiography using harmonic imaging withou

141 Myocardial contrast echocardiography was achieved with intracoronar

142 flow through IPAVAs as detected with saline contrast echocardiography was not different between cond

143 Myocardial contrast echocardiography was performed after IV injecti

144 Real-time contrast echocardiography was performed at baseline, dur

145 Triggered myocardial contrast echocardiography was performed during intraveno

146 Myocardial contrast echocardiography was performed during varying E

147 Myocardial contrast echocardiography was performed in six dogs to a

148 Contrast echocardiography was performed to assess RF and

149 vered as a constant infusion, and myocardial contrast echocardiography was performed using different

150 Myocardial contrast echocardiography was performed using intravenou

151 Low-power real-time myocardial contrast echocardiography was performed with flash impul

152 Perfusion defects on myocardial contrast echocardiography were measured during coronary

153 ng (WT) and myocardial perfusion (myocardial contrast echocardiography) were assessed at each stage.

154 scular reserve, studied by use of myocardial contrast echocardiography, were measured both before and

155 At the start of myocardial contrast echocardiography, which lasted 10 minutes, perf

156 Myocardial contrast echocardiography with 1:4 electrocardiographic

157 Hg (or > or =20 mm Hg if age > 64 years) and contrast echocardiography with late appearance of microb